Nabila El-Bassel, James L David, Eric Aragundi, Scott T Walters, Elwin Wu, Louisa Gilbert, Redonna Chandler, Tim Hunt, Victoria Frye, Aimee N C Campbell, Dawn A Goddard-Erich, Marc Chen, Parixit Davé, Shoshana N Benjamin, David Lounsbury, Nasim Sabounchi, Maneesha Aggarwal, Dan Feaster, Terry Huang, Tian Zheng
{"title":"Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings.","authors":"Nabila El-Bassel, James L David, Eric Aragundi, Scott T Walters, Elwin Wu, Louisa Gilbert, Redonna Chandler, Tim Hunt, Victoria Frye, Aimee N C Campbell, Dawn A Goddard-Erich, Marc Chen, Parixit Davé, Shoshana N Benjamin, David Lounsbury, Nasim Sabounchi, Maneesha Aggarwal, Dan Feaster, Terry Huang, Tian Zheng","doi":"10.1097/ADM.0000000000001534","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This paper describes how artificial intelligence (AI) was used to analyze meeting minutes from community coalitions participating in the HEALing Communities Study. We examined how often coalitions discussed stigma when selecting evidence-based practices (EBPs), variations in stigma-related discussions across coalitions, how these discussions addressed race, ethnicity, and racial inequity, and whether the frequency of stigma discussions was associated with the proportion of minoritized populations in each community.</p><p><strong>Methods: </strong>We used Natural Language Processing, Machine Learning, and Large Language Models, employing ChatGPT Enterprise to code data, ensuring data security and privacy compliance with the General Data Protection Regulation and HIPAA.</p><p><strong>Results: </strong>Community coalitions varied in the extent to which they discussed stigma during meetings focused on EBPs to reduce overdose deaths. Stigma was mentioned more frequently in the context of medication for opioid use disorder compared with other EBPs. As the percentage of racial/ethnic minority populations increased in a county, so did the strength of the association between discussions of EBPs and stigma. Counties with a greater proportion of racial/ethnic minority populations were more likely to integrate discussions of EBPs with stigma-related issues. Specifically, discussions about stigma were ~57% more likely to occur when racial or ethnic disparities were mentioned, compared with when they were not (odds ratio=1.57; 95% CI: 1.22, 2.03).</p><p><strong>Conclusions: </strong>The paper highlights the potential for integrating AI-human collaboration into community-engaged research, particularly in leveraging qualitative data such as meeting minutes. It shows how AI can be used in real-time to enhance community-based research.</p>","PeriodicalId":14744,"journal":{"name":"Journal of Addiction Medicine","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Addiction Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ADM.0000000000001534","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This paper describes how artificial intelligence (AI) was used to analyze meeting minutes from community coalitions participating in the HEALing Communities Study. We examined how often coalitions discussed stigma when selecting evidence-based practices (EBPs), variations in stigma-related discussions across coalitions, how these discussions addressed race, ethnicity, and racial inequity, and whether the frequency of stigma discussions was associated with the proportion of minoritized populations in each community.
Methods: We used Natural Language Processing, Machine Learning, and Large Language Models, employing ChatGPT Enterprise to code data, ensuring data security and privacy compliance with the General Data Protection Regulation and HIPAA.
Results: Community coalitions varied in the extent to which they discussed stigma during meetings focused on EBPs to reduce overdose deaths. Stigma was mentioned more frequently in the context of medication for opioid use disorder compared with other EBPs. As the percentage of racial/ethnic minority populations increased in a county, so did the strength of the association between discussions of EBPs and stigma. Counties with a greater proportion of racial/ethnic minority populations were more likely to integrate discussions of EBPs with stigma-related issues. Specifically, discussions about stigma were ~57% more likely to occur when racial or ethnic disparities were mentioned, compared with when they were not (odds ratio=1.57; 95% CI: 1.22, 2.03).
Conclusions: The paper highlights the potential for integrating AI-human collaboration into community-engaged research, particularly in leveraging qualitative data such as meeting minutes. It shows how AI can be used in real-time to enhance community-based research.
期刊介绍:
The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty.
Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including:
•addiction and substance use in pregnancy
•adolescent addiction and at-risk use
•the drug-exposed neonate
•pharmacology
•all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances
•diagnosis
•neuroimaging techniques
•treatment of special populations
•treatment, early intervention and prevention of alcohol and drug use disorders
•methodological issues in addiction research
•pain and addiction, prescription drug use disorder
•co-occurring addiction, medical and psychiatric disorders
•pathological gambling disorder, sexual and other behavioral addictions
•pathophysiology of addiction
•behavioral and pharmacological treatments
•issues in graduate medical education
•recovery
•health services delivery
•ethical, legal and liability issues in addiction medicine practice
•drug testing
•self- and mutual-help.